Search

Author/Creator Gavin, John

3. In Response to Letter to the Editor Regarding In‐Office Tympanostomy Tube Placement in Children Using Iontophoresis and Automated Tube Delivery. (16th October 2020)

Authors:
Lustig, Lawrence R.; Grunstein, Eli; Hills, Susannah; Ingram, Amy; Gould, Andrew R.; Vidrine, D. Macy; Puchalski, Robert; Zeiders, Jacob W.; Ow, Randall A.; Thompson, Christopher R.; Moss, Jonathan R.; Mehta, Ritvik; Calzada, Audrey; McClay, John E.; Brenski, Amy; Gavin, John; Waldman, Erik H.; A...
Journal:
Laryngoscope
Issue:
Volume 131:Number 3(2021)
Page Start:
E978
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. In‐Office Tympanostomy Tube Placement in Children Using Iontophoresis and Automated Tube Delivery. (11th March 2020)

Authors:
Lustig, Lawrence R.; Ingram, Amy; Vidrine, D. Macy; Gould, Andrew R.; Zeiders, Jacob W.; Ow, Randall A.; Thompson, Christopher R.; Moss, Jonathan R.; Mehta, Ritvik; McClay, John E.; Brenski, Amy; Gavin, John; Waldman, Erik H.; Ansley, John; Yen, David M.; Chadha, Neil K.; Murray, Michael T.; Koza...
Journal:
Laryngoscope
Issue:
Volume 130(2020)Supplement 4
Page Start:
S1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial. Issue 10318 (18th December 2021)

Authors:
Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; va...
Journal:
Lancet
Issue:
Volume 398:Issue 10318(2021)
Page Start:
2258
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial. Issue 8 (August 2022)

Authors:
Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Al...
Journal:
Lancet infectious diseases
Issue:
Volume 22:Issue 8(2022)
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗